EQT
50
3
MOS
38
2
EXR
31
-11
MDLZ
30
2
DIS
68
-2
FLR
50
11
NWSA
71
2
EQIX
57
-2
ADI
57
2
CNP
52
-7
INTC
37
2
MSI
54
2
WFC
60
2
BMY
38
-3
XRX
59
11
DAL
61
3
WY
36
5
CCI
20
-11
PSA
45
2
MA
62
2
EQT
50
3
MOS
38
2
EXR
31
-11
MDLZ
30
2
DIS
68
-2
FLR
50
11
NWSA
71
2
EQIX
57
-2
ADI
57
2
CNP
52
-7
INTC
37
2
MSI
54
2
WFC
60
2
BMY
38
-3
XRX
59
11
DAL
61
3
WY
36
5
CCI
20
-11
PSA
45
2
MA
62
2
Financhill
Back

Vera Therapeutics 10K Form

Sell
17

VERA
Vera Therapeutics

Last Price:
$42.26
Seasonality Move:
28.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive VERA News And Ratings

See the #1 stock for the next 7 days that we like better than VERA

VERA Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-37.1M
Price / Cash Flow: 0
Annual Sales: $5.25
Price / Book: 9.27

Profitability

EPS (TTM): -2.61000
Net Income (TTM): $-134.4M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Vera Therapeutics Earnings Forecast

Key Vera Therapeutics Financial Ratios

  • The Interest Expense is -3.94% of Operating Income.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Vera Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: VERA
Website: veratx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

VERA Technical Analysis vs Fundamental Analysis

Sell
17
Vera Therapeutics (VERA) is a Sell

Is Vera Therapeutics a Buy or a Sell?

  • Vera Therapeutics stock is rated a Sell
    The current Vera Therapeutics [VERA] share price is $42.31. The Score for VERA is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.